Erin W. Meermeier
WinnMed(US)Mayo Clinic in Arizona(US)Mayo Clinic Hospital(US)Arizona Oncology(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Immune Cell Function and Interaction, Peptidase Inhibition and Analysis, CAR-T cell therapy research
Most-Cited Works
- → Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection(2018)559 cited
- → MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage(2018)146 cited
- → Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens(2016)122 cited
- → Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy(2021)98 cited
- → TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis(2019)83 cited
- → MAIT cells and microbial immunity(2018)78 cited
- →